Adverse drug reaction (ADR) is a common clinical problem, sometimes accompanying with high risk of mortality and morbidity.It is also one of the major factors that lead to failure in new drug development.Unfortunately, most of current experimental and computational methods are unable to evaluate clinical safety of drug candidates in early drug discovery stage due to the very limited knowledge of molecular mechanisms underlying ADRs.